These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25757272)

  • 1. [Progress in the personalized medicine using pharmacometabonomics].
    Huang Q; A JY; Zhou GH
    Yao Xue Xue Bao; 2014 Nov; 49(11):1491-7. PubMed ID: 25757272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacometabonomics - the novel way to personalized drug therapy].
    Maslov DL; Balashova EE; Lokhov PG; Archakov AI
    Biomed Khim; 2017 Mar; 63(2):115-123. PubMed ID: 28414282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.
    Li B; He X; Jia W; Li H
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28703775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacometabonomics: data processing and statistical analysis.
    Fu J; Zhang Y; Liu J; Lian X; Tang J; Zhu F
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine.
    Everett JR
    Front Pharmacol; 2016; 7():297. PubMed ID: 27660611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabonomics as an effector for personalized medicine.
    Nicholson JK; Wilson ID; Lindon JC
    Pharmacogenomics; 2011 Jan; 12(1):103-11. PubMed ID: 21174625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
    Frédérich M; Pirotte B; Fillet M; de Tullio P
    J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.
    Nicholson JK; Everett JR; Lindon JC
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics and Personalized Medicine.
    Koen N; Du Preez I; Loots du T
    Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discussion on studies of individualized diagnosis and treatment using metabonomics].
    Li YS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):981-4. PubMed ID: 21866674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 16. A Unified Conceptual Framework for Metabolic Phenotyping in Diagnosis and Prognosis.
    Everett JR; Holmes E; Veselkov KA; Lindon JC; Nicholson JK
    Trends Pharmacol Sci; 2019 Oct; 40(10):763-773. PubMed ID: 31511194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of osteoporosis: towards novel theranostics for personalized medicine?
    Rojo Venegas K; Aguilera Gómez M; Cañada Garre M; Sánchez AG; Contreras-Ortega C; Calleja Hernández MA
    OMICS; 2012 Dec; 16(12):638-51. PubMed ID: 23215803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometabonomics, pharmacogenomics and personalized medicine.
    Guţiu IA; Andrieş A; Mircioiu C; Rădulescu F; Georgescu AM; Cioacă D
    Rom J Intern Med; 2010; 48(2):187-91. PubMed ID: 21428184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex assay for multiomics advances in personalized-precision medicine.
    Popa ML; Albulescu R; Neagu M; Hinescu ME; Tanase C
    J Immunoassay Immunochem; 2019; 40(1):3-25. PubMed ID: 30632882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.